oxycodone and Idiopathic Parkinson Disease

oxycodone has been researched along with Idiopathic Parkinson Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Bruno, V; Farcy, N; Karnik, V; Zamorano, C1
Buhidma, Y; Duty, S; Leta, V; Malcangio, M; Ray Chaudhuri, K; Rukavina, K; Sportelli, C1
Dauri, M; Madeo, G; Natoli, S; Pierantozzi, M; Pisani, A; Schirinzi, T; Stefani, A1
Antonini, A; Tinazzi, M1
Chaudhuri, KR; DeCesare, J; Ehret, R; Hopp, M; Krygowska-Wajs, A; Lomax, M; Marti, MJ; Martinez-Martin, P; Oksche, A; Rascol, O; Reimer, K; Sátori, M; Trenkwalder, C; Vališ, M1
Herkes, GK; McKay, D; Meagher, LJ; Needham, M1

Reviews

2 review(s) available for oxycodone and Idiopathic Parkinson Disease

ArticleYear
Current Status of Pain Management in Parkinson's Disease.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2020, Volume: 47, Issue:3

    Topics: Acetylcholine Release Inhibitors; Alanine; Analgesics; Antiparkinson Agents; Apomorphine; Benzylamines; Botulinum Toxins, Type A; Deep Brain Stimulation; Dopamine Agonists; Drug Combinations; Duloxetine Hydrochloride; Humans; Levodopa; Naloxone; Oxycodone; Pain; Pain Management; Pain Measurement; Pain Threshold; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes

2020
Pain in Parkinson's disease: new concepts in pathogenesis and treatment.
    Current opinion in neurology, 2019, Volume: 32, Issue:4

    Topics: Analgesics; Botulinum Toxins; Chronic Pain; Deep Brain Stimulation; Duloxetine Hydrochloride; Humans; Naloxone; Oxycodone; Pain Management; Parkinson Disease

2019

Trials

1 trial(s) available for oxycodone and Idiopathic Parkinson Disease

ArticleYear
Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial.
    The Lancet. Neurology, 2015, Volume: 14, Issue:12

    Topics: Aged; Analgesics, Opioid; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Naloxone; Oxycodone; Pain; Parkinson Disease; Treatment Outcome

2015

Other Studies

3 other study(ies) available for oxycodone and Idiopathic Parkinson Disease

ArticleYear
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson's disease patients with chronic pain.
    Journal of neurology, 2015, Volume: 262, Issue:9

    Topics: Aged; Aged, 80 and over; Chronic Pain; Delayed-Action Preparations; Drug Combinations; Female; Humans; Male; Middle Aged; Naloxone; Oxycodone; Parkinson Disease; Prospective Studies; Quality of Life; Treatment Outcome

2015
Targeting pain in Parkinson's disease.
    The Lancet. Neurology, 2015, Volume: 14, Issue:12

    Topics: Analgesics, Opioid; Female; Humans; Male; Naloxone; Oxycodone; Pain; Parkinson Disease

2015
Parkinsonism-hyperpyrexia syndrome: the role of electroconvulsive therapy.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2006, Volume: 13, Issue:8

    Topics: Acetaminophen; Acyclovir; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Anxiety Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiparkinson Agents; Antiviral Agents; Anxiety; Carbidopa; Ceftriaxone; Cervical Vertebrae; Depression; Dexamethasone; Diazepam; Doxepin; Electroconvulsive Therapy; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Oxycodone; Pain; Parkinson Disease; Selegiline; Spinal Injuries

2006